EBIXA
Drug
H. Lundbeck A S
Total Payments
$20,533
Transactions
2
Doctors
1
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2017 | $20,533 | 2 | 1 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $10,533 | 1 | 51.3% |
| Honoraria | $10,000 | 1 | 48.7% |
Top Doctors Receiving Payments for EBIXA
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD PHD | Neurological Surgery | Boston, MA | $20,533 | 2 |
Ad
Manufacturing Companies
- H. Lundbeck A S $20,533
Product Information
- Type Drug
- Total Payments $20,533
- Total Doctors 1
- Transactions 2
About EBIXA
EBIXA is a drug associated with $20,533 in payments to 1 healthcare providers, recorded across 2 transactions in the CMS Open Payments database. The primary manufacturer is H. Lundbeck A S.
Payment data is available from 2017 to 2017. In 2017, $20,533 was paid across 2 transactions to 1 doctors.
The most common payment nature for EBIXA is "Travel and Lodging" ($10,533, 51.3% of total).